Table 2. Characteristics of the patients.
| Group | Variable | No. | Group | Variable | No. |
| Healthy (n=45) | Age, years | Cirrhosis (n = 45) | Age, years | ||
| mean | 29.608 | mean | 51.496 | ||
| SD | 11.331 | SD | 10.339 | ||
| Male | 26 | Male | 34 | ||
| female | 19 | female | 11 | ||
| Serum AFP | Serum AFP | ||||
| <20 ng/ml | 45 | <20 ng/ml | 33 | ||
| ≥20 ng/ml | 0 | =20–400 ng/ml | 10 | ||
| >400 ng/ml | 2 | ||||
| Hepatitis (n=45) | Age, years | liver cancer (n = 45) | Age, years | ||
| mean | 41.143 | mean | 52.333 | ||
| SD | 13.155 | SD | 11.909 | ||
| Male | 38 | Male | 36 | ||
| female | 7 | female | 9 | ||
| Serum AFP | Serum AFP | ||||
| <20 ng/ml | 20 | <20 ng/ml | 16 | ||
| =20–400 ng/ml | 19 | =20–400 ng/ml | 12 | ||
| >400 ng/ml | 6 | >400 ng/ml | 17 |